The analysis, published in Radiology, included more than 300 patients who presented with severe aortic stenosis.
The recommendation, made specifically with high-risk patients in mind, includes ECGs, X-rays and more.
The team hopes its findings, published in Advanced Functional Materials, could lead to significant improvements in patient care.
Experienced users were especially effective at diagnosing cardiac disease with a handheld device.
The FDA’s decision was based in part on two independent clinical studies published in 2020.
Innovate Healthcare thanks our partners for supporting our newsletters.Sponsorship has no influence on editorial content.Interested in reaching our audiences, contact our team*|LIST:ADDRESSLINE|*You received this email because you signed up for newsletters from Innovate Healthcare.Change your preferences or unsubscribe hereContact Us | Unsubscribe from all | Privacy Policy© Innovate Healthcare, a TriMed Media brand
